NEXGEL Audit Committee Chair Resigns Amid Internal Control Weaknesses
NXGL sits 18% above its 52-week low of $0.479.
Summary
Scott Henry has resigned from NEXGEL's Board of Directors, effective July 1, 2026, vacating his critical role as Audit Committee Chair. This departure is highly significant given the company's recent disclosure in its May 14th 10-Q of material weaknesses in internal controls and a reiterated going concern warning. The loss of the Audit Committee Chair raises serious concerns about the company's ability to address its financial oversight deficiencies and navigate its precarious financial position, which also includes a Nasdaq deficiency notice and ongoing shareholder votes on substantial dilution.
At the time of this announcement, NXGL was trading at $0.56 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6.7M. The 52-week trading range was $0.48 to $2.89. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.